{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T20:55:41Z","timestamp":1773608141340,"version":"3.50.1"},"reference-count":277,"publisher":"Elsevier","isbn-type":[{"value":"9780128152041","type":"print"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/bs.acc.2018.06.001","type":"book-chapter","created":{"date-parts":[[2018,8,18]],"date-time":"2018-08-18T08:12:27Z","timestamp":1534579947000},"page":"71-125","source":"Crossref","is-referenced-by-count":20,"title":["New Biomarkers to Evaluate Hyperandrogenemic Women and Hypogonadal Men"],"prefix":"10.1016","member":"78","reference":[{"issue":"8","key":"10.1016\/bs.acc.2018.06.001_bib1","first-page":"2759","article-title":"Clinical review 82: androgens and the postmenopausal woman","volume":"81","author":"Davis","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3 Suppl.","key":"10.1016\/bs.acc.2018.06.001_bib2","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1067\/mjd.2001.117431","article-title":"Ovarian hormones and adrenal androgens during a woman's life span","volume":"45","author":"Knochenhauer","year":"2001","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2265.1974.tb03298.x","article-title":"Sex-hormone-binding globulin","volume":"3","author":"Anderson","year":"1974","journal-title":"Clin. Endocrinol."},{"issue":"4\u20136","key":"10.1016\/bs.acc.2018.06.001_bib4","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0960-0760(91)90299-K","article-title":"The plasma sex steroid binding protein (SBP or SHBG). A critical review of recent developments on the structure, molecular biology and function","volume":"40","author":"Petra","year":"1991","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib5","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/humupd\/dmt038","article-title":"The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis","volume":"20","author":"Zimmerman","year":"2014","journal-title":"Hum. Reprod. Update"},{"issue":"5","key":"10.1016\/bs.acc.2018.06.001_bib6","doi-asserted-by":"crossref","first-page":"M409","DOI":"10.1093\/gerona\/58.5.M409","article-title":"Androgens and women at the menopause and beyond","volume":"58","author":"Morley","year":"2003","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"3","key":"10.1016\/bs.acc.2018.06.001_bib7","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1210\/jcem-73-3-674","article-title":"Normative data for adrenal steroidogenesis in a healthy pediatric population: age- and sex-related changes after adrenocorticotropin stimulation","volume":"73","author":"Lashansky","year":"1991","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/bs.acc.2018.06.001_bib8","first-page":"645","article-title":"Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study","volume":"85","author":"Laughlin","year":"2000","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"4","key":"10.1016\/bs.acc.2018.06.001_bib9","first-page":"1429","article-title":"Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women","volume":"80","author":"Zumoff","year":"1995","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"issue":"1\u20132","key":"10.1016\/bs.acc.2018.06.001_bib10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.steroids.2010.10.010","article-title":"Reexamination of testosterone, dihydrotestosterone, estradiol and estrone levels across the menstrual cycle and in postmenopausal women measured by liquid chromatography-tandem mass spectrometry","volume":"76","author":"Rothman","year":"2011","journal-title":"Steroids"},{"issue":"3","key":"10.1016\/bs.acc.2018.06.001_bib11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0378-5122(80)90001-8","article-title":"Evolution with ageing of four plasma androgens in postmenopausal women","volume":"2","author":"Roger","year":"1980","journal-title":"Maturitas"},{"issue":"9","key":"10.1016\/bs.acc.2018.06.001_bib12","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1210\/jc.2011-2744","article-title":"An approach to the patient with hirsutism","volume":"97","author":"Loriaux","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2018.06.001_bib13","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman","year":"1961","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/humupd\/dmp024","article-title":"Visually scoring hirsutism","volume":"16","author":"Yildiz","year":"2010","journal-title":"Hum. Reprod. Update"},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib15","first-page":"15","article-title":"Androgenetic alopecia, Giornale italiano di dermatologia e venereologia : organo ufficiale","volume":"149","author":"Piraccini","year":"2014","journal-title":"Soci. Ital. Dermatol. Sifilogr."},{"issue":"5","key":"10.1016\/bs.acc.2018.06.001_bib16","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1177\/000313481408000517","article-title":"Hair loss in females after sleeve gastrectomy: predictive value of serum zinc and iron levels","volume":"80","author":"Ruiz-Tovar","year":"2014","journal-title":"Am. Surg."},{"key":"10.1016\/bs.acc.2018.06.001_bib17","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.cca.2017.06.009","article-title":"New biomarkers for diagnosis and management of polycystic ovary syndrome","volume":"471","author":"Karakas","year":"2017","journal-title":"Clin. Chim. Acta"},{"issue":"6","key":"10.1016\/bs.acc.2018.06.001_bib18","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2018.06.001_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000341673","article-title":"Polycystic ovary syndrome: definitions, phenotypes and diagnostic approach","volume":"40","author":"Livadas","year":"2013","journal-title":"Front. Horm. Res."},{"issue":"12","key":"10.1016\/bs.acc.2018.06.001_bib20","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum. Reprod."},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil. Steril."},{"issue":"11","key":"10.1016\/bs.acc.2018.06.001_bib22","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/humupd\/dmq032","article-title":"Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence","volume":"17","author":"Qiao","year":"2011","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/bs.acc.2018.06.001_bib24","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1477-7827-9-116","article-title":"The role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment?,","volume":"9","author":"Gleicher","year":"2011","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"4","key":"10.1016\/bs.acc.2018.06.001_bib25","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1095\/biolreprod.107.067280","article-title":"Functional AR signaling is evident in an in vitro mouse follicle culture bioassay that encompasses most stages of folliculogenesis","volume":"80","author":"Lenie","year":"2009","journal-title":"Biol. Reprod."},{"issue":"7","key":"10.1016\/bs.acc.2018.06.001_bib26","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1210\/me.2010-0006","article-title":"Granulosa cell-specific androgen receptors are critical regulators of ovarian development and function","volume":"24","author":"Sen","year":"2010","journal-title":"Mol. Endocrinol."},{"issue":"2","key":"10.1016\/bs.acc.2018.06.001_bib27","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1210\/en.2009-0751","article-title":"Testosterone induces redistribution of forkhead box-3a and down-regulation of growth and differentiation factor 9 messenger ribonucleic acid expression at early stage of mouse folliculogenesis","volume":"151","author":"Yang","year":"2010","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/OGX.0b013e31815e85fc","article-title":"Polycystic ovary syndrome and oocyte developmental competence","volume":"63","author":"Dumesic","year":"2008","journal-title":"Obstet. Gynecol. Surv."},{"issue":"12","key":"10.1016\/bs.acc.2018.06.001_bib29","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1210\/jcem.86.12.8088","article-title":"The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome","volume":"86","author":"Nelson","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/bs.acc.2018.06.001_bib30","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1093\/humrep\/15.12.2471","article-title":"Comparison of follicle steroidogenesis from normal and polycystic ovaries in women undergoing IVF: relationship between steroid concentrations, follicle size, oocyte quality and fecundability","volume":"15","author":"Teissier","year":"2000","journal-title":"Hum. Reprod."},{"issue":"2","key":"10.1016\/bs.acc.2018.06.001_bib31","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4103\/0974-1208.183515","article-title":"Effective treatment protocol for poor ovarian response: a systematic review and meta-analysis","volume":"9","author":"Jeve","year":"2016","journal-title":"J. Hum. Reprod. Sci."},{"issue":"3","key":"10.1016\/bs.acc.2018.06.001_bib32","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ijgo.2015.06.028","article-title":"A meta-analysis of dehydroepiandrosterone supplementation among women with diminished ovarian reserve undergoing in vitro fertilization or intracytoplasmic sperm injection","volume":"131","author":"Li","year":"2015","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"8","key":"10.1016\/bs.acc.2018.06.001_bib33","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s10815-016-0713-5","article-title":"Dehydroepiandrosterone treatment in women with poor ovarian response undergoing IVF or ICSI: a systematic review and meta-analysis","volume":"33","author":"Zhang","year":"2016","journal-title":"J. Assist. Reprod. Genet."},{"issue":"11","key":"10.1016\/bs.acc.2018.06.001_bib34","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1001\/jama.295.11.1288","article-title":"Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis","volume":"295","author":"Ding","year":"2006","journal-title":"J. Am. Med. Assoc."},{"issue":"12","key":"10.1016\/bs.acc.2018.06.001_bib35","first-page":"4420","article-title":"Effects of methyltestosterone on insulin secretion and sensitivity in women","volume":"83","author":"Diamond","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/bs.acc.2018.06.001_bib36","doi-asserted-by":"crossref","first-page":"e108263","DOI":"10.1371\/journal.pone.0108263","article-title":"Hyperandrogenemia in polycystic ovary syndrome: exploration of the role of free testosterone and androstenedione in metabolic phenotype","volume":"9","author":"Lerchbaum","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/bs.acc.2018.06.001_bib37","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s12020-014-0200-7","article-title":"Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome","volume":"47","author":"Livadas","year":"2014","journal-title":"Endocrine"},{"issue":"8","key":"10.1016\/bs.acc.2018.06.001_bib38","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.2337\/dc11-0596","article-title":"Low free testosterone levels are associated with all-cause and cardiovascular mortality in postmenopausal diabetic women","volume":"34","author":"Wehr","year":"2011","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/bs.acc.2018.06.001_bib39","doi-asserted-by":"crossref","first-page":"828","DOI":"10.2337\/diacare.21.5.828","article-title":"Do postmenopausal women with NIDDM have a reduced capacity to deposit and conserve lower-body fat?","volume":"21","author":"Stoney","year":"1998","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/bs.acc.2018.06.001_bib40","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0953-6205(00)00122-9","article-title":"Association of increased C-peptide serum levels and testosterone in type 2 diabetes","volume":"11","author":"Zietz","year":"2000","journal-title":"Eur. J. Intern. Med."},{"issue":"4","key":"10.1016\/bs.acc.2018.06.001_bib41","first-page":"271","article-title":"Sex\u00a0hormone-binding globulin genetic variation: associations with type 2 diabetes\u00a0mellitus and polycystic ovary syndrome","volume":"35","author":"Chen","year":"2010","journal-title":"Minerva Endocrinol."},{"issue":"2","key":"10.1016\/bs.acc.2018.06.001_bib42","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejim.2007.09.023","article-title":"SHBG levels correlate with insulin resistance in postmenopausal women","volume":"20","author":"Akin","year":"2009","journal-title":"Eur. J. Intern. Med."},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib43","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12905-017-0373-3","article-title":"Sex hormone binding globulin as a valuable biochemical marker in predicting gestational diabetes mellitus","volume":"17","author":"Tawfeek","year":"2017","journal-title":"BMC Women's Health"},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib44","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/1354750X.2016.1204010","article-title":"Sex hormone-binding globulin and thrombin generation in women using hormonal contraception","volume":"22","author":"Hugon-Rodin","year":"2017","journal-title":"Biomarkers"},{"issue":"6","key":"10.1016\/bs.acc.2018.06.001_bib45","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.fertnstert.2014.02.039","article-title":"Influence of oral contraceptives on anthropomorphometric, endocrine, and metabolic profiles of anovulatory polycystic ovary syndrome patients","volume":"101","author":"Mes-Krowinkel","year":"2014","journal-title":"Fertil. Steril."},{"issue":"2","key":"10.1016\/bs.acc.2018.06.001_bib46","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/molehr\/gah015","article-title":"Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment","volume":"10","author":"Weenen","year":"2004","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/bs.acc.2018.06.001_bib47","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejogrb.2016.01.029","article-title":"The role of anti-Mullerian hormone in the pathogenesis and pathophysiological characteristics of polycystic ovary syndrome","volume":"199","author":"Qi","year":"2016","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"8","key":"10.1016\/bs.acc.2018.06.001_bib48","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/molehr\/gat024","article-title":"Which follicles make the most anti-Mullerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection","volume":"19","author":"Jeppesen","year":"2013","journal-title":"Mol. Hum. Reprod."},{"issue":"3","key":"10.1016\/bs.acc.2018.06.001_bib49","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/humupd\/dmt062","article-title":"The physiology and clinical utility of anti-Mullerian hormone in women","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum. Reprod. Update"},{"issue":"2","key":"10.1016\/bs.acc.2018.06.001_bib50","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.fertnstert.2014.10.033","article-title":"Each small antral follicle in ovaries of women with polycystic ovary syndrome produces more antimullerian hormone than its counterpart in a normal ovary: an observational cross-sectional study","volume":"103","author":"Bhide","year":"2015","journal-title":"Fertil. Steril."},{"issue":"4","key":"10.1016\/bs.acc.2018.06.001_bib51","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/humrep\/det015","article-title":"The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study","volume":"28","author":"Homburg","year":"2013","journal-title":"Hum. Reprod."},{"issue":"12","key":"10.1016\/bs.acc.2018.06.001_bib52","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/aogs.12247","article-title":"Elevated serum levels of anti-Mullerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome","volume":"92","author":"Sahmay","year":"2013","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"9","key":"10.1016\/bs.acc.2018.06.001_bib53","first-page":"1866","article-title":"Anti mullerian hormone: a potential marker for recruited non growing follicle of ovarian pool in women with polycystic ovarian syndrome","volume":"7","author":"Saikumar","year":"2013","journal-title":"J. Clin. Diagn. Res."},{"issue":"3","key":"10.1016\/bs.acc.2018.06.001_bib54","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1055\/s-0034-1371091","article-title":"Diagnosis and challenges of polycystic ovary syndrome in adolescence","volume":"32","author":"Agapova","year":"2014","journal-title":"Semin. Reprod. Med."},{"issue":"1\u20132","key":"10.1016\/bs.acc.2018.06.001_bib55","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1515\/jpem-2014-0242","article-title":"Anti-Mullerian hormone levels in American girls by age and race\/ethnicity","volume":"28","author":"Elchuri","year":"2015","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/bs.acc.2018.06.001_bib56","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00404-014-3317-2","article-title":"Anti-Mullerian Hormone: an indicator for the severity of polycystic ovarian syndrome","volume":"290","author":"Koninger","year":"2014","journal-title":"Arch. Gynecol. Obstet."},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib57","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejogrb.2013.05.019","article-title":"Serum anti-Mullerian hormone levels in the main phenotypes of polycystic ovary syndrome","volume":"170","author":"Sahmay","year":"2013","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"2","key":"10.1016\/bs.acc.2018.06.001_bib58","doi-asserted-by":"crossref","first-page":"E238","DOI":"10.1152\/ajpendo.90684.2008","article-title":"Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels","volume":"296","author":"Piouka","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2018.06.001_bib59","article-title":"Relationship between anti-Mullerian hormone and antral follicle count across the menstrual cycle using the Beckman Coulter Access assay in comparison with Gen II manual assay","author":"Schiffner","year":"2016","journal-title":"Clin. Chem. Lab. Med."},{"issue":"6","key":"10.1016\/bs.acc.2018.06.001_bib60","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.rbmo.2012.09.001","article-title":"Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception","volume":"25","author":"Bentzen","year":"2012","journal-title":"Reprod. Biomed. Online"},{"issue":"5","key":"10.1016\/bs.acc.2018.06.001_bib61","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.fertnstert.2012.11.034","article-title":"Antimullerian hormone levels decrease in women using combined contraception independently of administration route","volume":"99","author":"Kallio","year":"2013","journal-title":"Fertil. Steril."},{"issue":"12","key":"10.1016\/bs.acc.2018.06.001_bib62","doi-asserted-by":"crossref","first-page":"E1961","DOI":"10.1210\/jc.2013-2410","article-title":"The impact of depot GnRH agonist on AMH levels in healthy reproductive-aged women,","volume":"98","author":"Su","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib63","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3109\/09513590.2012.705372","article-title":"Changes of endocrine and ultrasound markers as ovarian aging in modifying the Stages of Reproductive Aging Workshop (STRAW) staging system with subclassification of mid reproductive age stage","volume":"29","author":"Ding","year":"2013","journal-title":"Gynecol. Endocrinol."},{"issue":"5","key":"10.1016\/bs.acc.2018.06.001_bib64","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.fertnstert.2017.08.029","article-title":"Female age, serum antimullerian hormone level, and number of oocytes affect the rate and number of euploid blastocysts in in vitro fertilization\/intracytoplasmic sperm injection cycles","volume":"108","author":"La Marca","year":"2017","journal-title":"Fertil. Steril."},{"issue":"2","key":"10.1016\/bs.acc.2018.06.001_bib65","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/humupd\/dmp036","article-title":"Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)","volume":"16","author":"La Marca","year":"2010","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/bs.acc.2018.06.001_bib66","first-page":"1","article-title":"Features of polycystic ovary syndrome (PCOS) in women with functional hypothalamic amenorrhea (FHA) may be reversible with recovery of menstrual function","author":"Carmina","year":"2017","journal-title":"Gynecol. Endocrinol."},{"issue":"6","key":"10.1016\/bs.acc.2018.06.001_bib67","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nrendo.2011.224","article-title":"Anti-Mullerian hormone: an ovarian reserve marker in primary ovarian insufficiency","volume":"8","author":"Visser","year":"2012","journal-title":"Nat. Rev. Endocrinol."},{"issue":"2","key":"10.1016\/bs.acc.2018.06.001_bib68","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jpag.2014.05.012","article-title":"Evidence to incorporate inclusive reproductive health measures in guidelines for childhood and adolescent cancer survivors","volume":"28","author":"Salih","year":"2015","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"issue":"9","key":"10.1016\/bs.acc.2018.06.001_bib69","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.12783","article-title":"Relative levels of the proprotein and cleavage-activated form of circulating human anti-Mullerian hormone are sexually dimorphic and variable during the life cycle","volume":"4","author":"Pankhurst","year":"2016","journal-title":"Physiol. Rep."},{"issue":"10","key":"10.1016\/bs.acc.2018.06.001_bib70","doi-asserted-by":"crossref","first-page":"E1241","DOI":"10.1152\/ajpendo.00395.2013","article-title":"Human blood contains both the uncleaved precursor of anti-Mullerian hormone and a complex of the NH2- and COOH-terminal peptides","volume":"305","author":"Pankhurst","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/bs.acc.2018.06.001_bib71","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/bs.acc.2018.06.001_bib72","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1055\/s-2003-43307","article-title":"21-hydroxylase-deficient nonclassic adrenal hyperplasia: the great pretender","volume":"21","author":"Moran","year":"2003","journal-title":"Semin. Reprod. Med."},{"key":"10.1016\/bs.acc.2018.06.001_bib73","doi-asserted-by":"crossref","first-page":"625105","DOI":"10.1186\/1687-9856-2010-625105","article-title":"Nonclassic congenital adrenal hyperplasia","volume":"2010","author":"Witchel","year":"2010","journal-title":"Int. J. Pediatr. Endocrinol."},{"issue":"9","key":"10.1016\/bs.acc.2018.06.001_bib74","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1210\/jc.2009-2631","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline","volume":"95","author":"Speiser","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/bs.acc.2018.06.001_bib75","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1177\/0004563217704738","article-title":"Low dehydroepiandrosterone sulphate: a sensitive and specific test for the detection of subclinical hypercortisolism in adrenal incidentalomas","volume":"54","author":"Stoddart","year":"2017","journal-title":"Ann. Clin. Biochem."},{"issue":"2","key":"10.1016\/bs.acc.2018.06.001_bib76","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11102-015-0634-9","article-title":"Screening for Cushing's syndrome: is it worthwhile?","volume":"18","author":"Shimon","year":"2015","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1006380306781","article-title":"The diagnostic and prognostic utility of prostate-specific antigen for diseases of the breast","volume":"59","author":"Black","year":"2000","journal-title":"Breast Cancer Res. Treat."},{"issue":"2","key":"10.1016\/bs.acc.2018.06.001_bib78","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0094-0143(05)70373-6","article-title":"Nonprostatic sources of prostate-specific antigen","volume":"24","author":"Diamandis","year":"1997","journal-title":"Urol. Clin."},{"issue":"10","key":"10.1016\/bs.acc.2018.06.001_bib79","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/clinchem\/45.10.1774","article-title":"Human glandular kallikrein in breast milk, amniotic fluid, and breast cyst fluid","volume":"45","author":"Magklara","year":"1999","journal-title":"Clin. Chem."},{"issue":"11","key":"10.1016\/bs.acc.2018.06.001_bib80","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1515\/cclm-2016-1124","article-title":"Serum complexed and free prostate-specific antigen (PSA) for the diagnosis of the polycystic ovarian syndrome (PCOS)","volume":"55","author":"Diamandis","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"issue":"6 Pt 1","key":"10.1016\/bs.acc.2018.06.001_bib81","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/clinchem\/46.6.859","article-title":"Serum and urinary prostate-specific antigen and urinary human glandular kallikrein concentrations are significantly increased after testosterone administration in female-to-male transsexuals","volume":"46","author":"Obiezu","year":"2000","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/bs.acc.2018.06.001_bib82","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1210\/jcem.86.4.7378","article-title":"Prostate-specific antigen and human glandular kallikrein 2 are markedly elevated in urine of patients with polycystic ovary syndrome","volume":"86","author":"Obiezu","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/bs.acc.2018.06.001_bib83","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1210\/jc.2013-3399","article-title":"Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione","volume":"99","author":"O'Reilly","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1\u20132","key":"10.1016\/bs.acc.2018.06.001_bib84","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mce.2004.02.011","article-title":"Inhibins and adult ovarian function","volume":"225","author":"Laven","year":"2004","journal-title":"Mol. Cell. Endocrinol."},{"issue":"1O","key":"10.1016\/bs.acc.2018.06.001_bib85","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1093\/humrep\/13.10.2693","article-title":"Inhibin A, inhibin B and activin A concentrations in follicular fluid from women with polycystic ovary syndrome","volume":"13","author":"Magoffin","year":"1998","journal-title":"Hum. Reprod."},{"issue":"Pt 3","key":"10.1016\/bs.acc.2018.06.001_bib86","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1258\/000456306776865188","article-title":"The LH\/FSH ratio has little use in diagnosing polycystic ovarian syndrome","volume":"43","author":"Cho","year":"2006","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/bs.acc.2018.06.001_bib87","first-page":"17","article-title":"Endocrinology update: hirsutism","volume":"451","author":"Heidelbaugh","year":"2016","journal-title":"FP Essent."},{"key":"10.1016\/bs.acc.2018.06.001_bib88","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bpobgyn.2016.05.003","article-title":"Androgen excess: investigations and management","volume":"37","author":"Lizneva","year":"2016","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/bs.acc.2018.06.001_bib89","article-title":"Combined oral contraception and bicalutamide in polycystic ovary syndrome and severe hirsutism - a double-blind RTC","author":"Moretti","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/bs.acc.2018.06.001_bib90","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/andr.274","article-title":"Systematic literature review of the risk factors, comorbidities, and consequences of hypogonadism in men","volume":"2","author":"Zarotsky","year":"2014","journal-title":"Andrology"},{"key":"10.1016\/bs.acc.2018.06.001_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/190347","article-title":"Systematic literature review of the epidemiology of nongenetic forms of hypogonadism in adult males","volume":"2014","author":"Zarotsky","year":"2014","journal-title":"J. Horm."},{"issue":"2","key":"10.1016\/bs.acc.2018.06.001_bib92","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa0911101","article-title":"Identification of late-onset hypogonadism in middle-aged and elderly men","volume":"363","author":"Wu","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/bs.acc.2018.06.001_bib93","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1210\/jc.2009-2354","article-title":"Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline","volume":"95","author":"Bhasin","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib94","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/13685530802389628","article-title":"ISA, ISSAM, EAU, EAA AND ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males","volume":"12","author":"Wang","year":"2009","journal-title":"Aging Male"},{"issue":"6","key":"10.1016\/bs.acc.2018.06.001_bib95","doi-asserted-by":"crossref","first-page":"440","DOI":"10.4158\/EP.8.6.439","article-title":"American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients\u20132002 update","volume":"8","author":"Petak","year":"2002","journal-title":"Endocr. Pract."},{"key":"10.1016\/bs.acc.2018.06.001_bib96","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000176045","article-title":"Late-onset hypogonadism","volume":"37","author":"Gooren","year":"2009","journal-title":"Front. Horm. Res."},{"issue":"4","key":"10.1016\/bs.acc.2018.06.001_bib97","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0094-0143(02)00084-8","article-title":"Androgen deficiency in the aging male: when, who, and how to investigate and treat","volume":"29","author":"Morales","year":"2002","journal-title":"Urol. Clin. North. Am."},{"issue":"3 Suppl.","key":"10.1016\/bs.acc.2018.06.001_bib98","first-page":"3","article-title":"The epidemiology of partialandrogen deficiency in aging men (PADAM)","volume":"28","author":"Frajese","year":"2005","journal-title":"J. Endocrinol. Invest."},{"issue":"2","key":"10.1016\/bs.acc.2018.06.001_bib99","doi-asserted-by":"crossref","first-page":"M76","DOI":"10.1093\/gerona\/57.2.M76","article-title":"Andropause: clinical implications of the decline in serum testosterone levels with aging in men","volume":"57","author":"Matsumoto","year":"2002","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"4","key":"10.1016\/bs.acc.2018.06.001_bib100","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1210\/jc.2005-1830","article-title":"Testosterone and estradiol among older men","volume":"91","author":"Orwoll","year":"2006","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"11","key":"10.1016\/bs.acc.2018.06.001_bib101","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1210\/jc.2007-1245","article-title":"Prevalence of symptomatic androgen deficiency in men","volume":"92","author":"Araujo","year":"2007","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"12","key":"10.1016\/bs.acc.2018.06.001_bib102","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1210\/jc.2003-031719","article-title":"Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study","volume":"89","author":"Araujo","year":"2004","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"2","key":"10.1016\/bs.acc.2018.06.001_bib103","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1210\/jcem.86.2.7219","article-title":"Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore\u00a0Longitudinal Study of Aging","volume":"86","author":"Harman","year":"2001","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/bs.acc.2018.06.001_bib104","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.maturitas.2015.11.003","article-title":"EMAS position statement: testosterone replacement therapy in the aging male","volume":"84","author":"Dimopoulou","year":"2016","journal-title":"Maturitas"},{"issue":"9","key":"10.1016\/bs.acc.2018.06.001_bib105","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/gerona\/glv031","article-title":"Recruitment and screening for the testosterone trials","volume":"70","author":"Cauley","year":"2015","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"7","key":"10.1016\/bs.acc.2018.06.001_bib106","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa1506119","article-title":"Effects of testosterone treatment in older men","volume":"374","author":"Snyder","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/bs.acc.2018.06.001_bib107","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0950-351X(97)80302-3","article-title":"Declining gonadal function in elderly men","volume":"11","author":"Kaufman","year":"1997","journal-title":"Baillieres Clin. Endocrinol. Metab."},{"issue":"Pt 6","key":"10.1016\/bs.acc.2018.06.001_bib108","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1258\/acb.2010.010150","article-title":"Biochemical endocrinology of the hypogonadal male","volume":"47","author":"Belchetz","year":"2010","journal-title":"Ann. Clin. Biochem."},{"issue":"6","key":"10.1016\/bs.acc.2018.06.001_bib109","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1651-2227.2011.02274.x","article-title":"Morbidity and mortality in Klinefelter syndrome (47,XXY)","volume":"100","author":"Bojesen","year":"2011","journal-title":"Acta Paediatr."},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib110","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1210\/jc.2012-2382","article-title":"Clinical review: Klinefelter syndrome\u2013a clinical update","volume":"98","author":"Groth","year":"2013","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/bs.acc.2018.06.001_bib111","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/625434","article-title":"Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy","volume":"2012","author":"Surampudi","year":"2012","journal-title":"Int. J. Endocrinol."},{"issue":"6","key":"10.1016\/bs.acc.2018.06.001_bib112","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1210\/er.2009-0005","article-title":"Kisspeptin signaling in the brain","volume":"30","author":"Oakley","year":"2009","journal-title":"Endocr. Rev."},{"issue":"4","key":"10.1016\/bs.acc.2018.06.001_bib113","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2265.2009.03687.x","article-title":"The recent genetics of hypogonadotrophic hypogonadism - novel insights and new questions","volume":"72","author":"Semple","year":"2010","journal-title":"Clin. Endocrinol."},{"issue":"4","key":"10.1016\/bs.acc.2018.06.001_bib114","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/GCO.0b013e32833bb425","article-title":"Molecular causes of hypogonadotropic hypogonadism","volume":"22","author":"Topaloglu","year":"2010","journal-title":"Curr. Opin. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/bs.acc.2018.06.001_bib115","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/ng.306","article-title":"TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction","volume":"41","author":"Topaloglu","year":"2009","journal-title":"Nat. Genet."},{"issue":"7","key":"10.1016\/bs.acc.2018.06.001_bib116","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1210\/jc.2010-0176","article-title":"Nonsense mutations in FGF8 gene causing different degrees of human gonadotropin-releasing deficiency","volume":"95","author":"Trarbach","year":"2010","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/bs.acc.2018.06.001_bib117","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000312693","article-title":"FGFR1 mutations in Kallmann syndrome","volume":"39","author":"Villanueva","year":"2010","journal-title":"Front. Horm. Res."},{"key":"10.1016\/bs.acc.2018.06.001_bib118","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000312698","article-title":"Kallmann syndrome caused by mutations in the PROK2 and PROKR2 genes: pathophysiology and genotype-phenotype correlations","volume":"39","author":"Sarfati","year":"2010","journal-title":"Front. Horm. Res."},{"key":"10.1016\/bs.acc.2018.06.001_bib119","series-title":"Pituitary Disorders: Diagnosis and Management","first-page":"179","article-title":"Hypogonadism and male sexual function, in pituitary disorders: diagnosis and management","author":"Surampudi","year":"2013"},{"key":"10.1016\/bs.acc.2018.06.001_bib120","series-title":"Andrology: Male Reproductive Health and Dysfunction","first-page":"87","article-title":"Classification of andrological disorders","author":"T\u00fcttelmann","year":"2010"},{"issue":"3","key":"10.1016\/bs.acc.2018.06.001_bib121","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.cell.2006.01.026","article-title":"Sex steroids and the free hormone hypothesis","volume":"124","author":"Rosner","year":"2006","journal-title":"Cell"},{"issue":"10","key":"10.1016\/bs.acc.2018.06.001_bib122","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1210\/jc.2010-1314","article-title":"Toward excellence in testosterone testing: a consensus statement","volume":"95","author":"Rosner","year":"2010","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"10","key":"10.1016\/bs.acc.2018.06.001_bib123","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum","volume":"84","author":"Vermeulen","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/bs.acc.2018.06.001_bib124","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1210\/jcem-26-5-573","article-title":"Diurnal testosterone levels in peripheral plasma of human male subjects","volume":"26","author":"Resko","year":"1966","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/bs.acc.2018.06.001_bib125","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cca.2017.03.010","article-title":"Accuracy-based proficiency testing for testosterone measurements with immunoassays and liquid chromatography-mass spectrometry","volume":"469","author":"Cao","year":"2017","journal-title":"Clin. Chim. Acta"},{"issue":"4","key":"10.1016\/bs.acc.2018.06.001_bib126","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1210\/jc.2016-2935","article-title":"Harmonized reference ranges for circulating testosterone levels in men of four cohort studies in the United States and Europe","volume":"102","author":"Travison","year":"2017","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"4","key":"10.1016\/bs.acc.2018.06.001_bib127","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0039-128X(70)80124-6","article-title":"A radioimmunoassay for plasma testosterone","volume":"16","author":"Furuyama","year":"1970","journal-title":"Steroids"},{"issue":"7","key":"10.1016\/bs.acc.2018.06.001_bib128","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/clinchem\/17.7.581","article-title":"Antibodies to testosterone-3-bovine serum albumin, applied to assay of serum 17-beta-ol androgens","volume":"17","author":"Chen","year":"1971","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2018.06.001_bib129","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0009-8981(72)90421-4","article-title":"Radioimmunoassay of plasma testosterone","volume":"37","author":"Dufau","year":"1972","journal-title":"Clin. Chim. Acta"},{"issue":"6","key":"10.1016\/bs.acc.2018.06.001_bib130","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0022-4731(74)90103-4","article-title":"A simple radioimmunoassay for plasma testosterone plus 5alpha-dihydrotestosterone","volume":"5","author":"Wang","year":"1974","journal-title":"J. Steroid Biochem."},{"issue":"13","key":"10.1016\/bs.acc.2018.06.001_bib131","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.steroids.2008.07.003","article-title":"The impact of assay quality and reference ranges on clinical decision making in the diagnosis of androgen disorders","volume":"73","author":"Bhasin","year":"2008","journal-title":"Steroids"},{"issue":"2","key":"10.1016\/bs.acc.2018.06.001_bib132","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1210\/jc.2003-031287","article-title":"Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry","volume":"89","author":"Wang","year":"2004","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"6","key":"10.1016\/bs.acc.2018.06.001_bib133","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.steroids.2009.01.008","article-title":"A novel spreadsheet method for calculating the free serum concentrations of testosterone, dihydrotestosterone, estradiol, estrone and cortisol: with illustrative examples from male and female populations","volume":"74","author":"Mazer","year":"2009","journal-title":"Steroids"},{"key":"10.1016\/bs.acc.2018.06.001_bib134","doi-asserted-by":"crossref","first-page":"35539","DOI":"10.1038\/srep35539","article-title":"Sex hormone-binding globulin regulation of androgen bioactivity in vivo: validation of the free hormone hypothesis","volume":"6","author":"Laurent","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/bs.acc.2018.06.001_bib135","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.mce.2016.08.041","article-title":"Effects of sex hormone-binding globulin (SHBG) on androgen bioactivity in vitro","volume":"437","author":"Laurent","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"issue":"9","key":"10.1016\/bs.acc.2018.06.001_bib136","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/jama.2012.227","article-title":"Effect of testosterone supplementation with and without a dual 5alpha-reductase inhibitor on fat-free mass in men with suppressed testosterone production: a randomized controlled trial","volume":"307","author":"Bhasin","year":"2012","journal-title":"J. Am. Med. Assoc."},{"issue":"11\u201312","key":"10.1016\/bs.acc.2018.06.001_bib137","first-page":"625","article-title":"Reference intervals for testosterone, androstenedione and SHBG levels in healthy females and males from birth until old age","volume":"51","author":"Elmlinger","year":"2005","journal-title":"Clin. Lab."},{"issue":"4","key":"10.1016\/bs.acc.2018.06.001_bib138","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1530\/EJE-16-0834","article-title":"Modulation of SHBG binding to testosterone and estradiol by sex and morbid obesity","volume":"176","author":"Grasa","year":"2017","journal-title":"Eur. J. Endocrinol."},{"issue":"9","key":"10.1016\/bs.acc.2018.06.001_bib139","doi-asserted-by":"crossref","first-page":"e0161297","DOI":"10.1371\/journal.pone.0161297","article-title":"Long-term effects of a randomised controlled trial comparing high protein or high carbohydrate weight loss diets on testosterone, SHBG, erectile and urinary function in overweight and obese men","volume":"11","author":"Moran","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/bs.acc.2018.06.001_bib140","article-title":"Sex hormone-binding globulin is associated with androgen deficiency features independently of total testosterone","author":"Rastrelli","year":"2017","journal-title":"Clin. Endocrinol."},{"issue":"12","key":"10.1016\/bs.acc.2018.06.001_bib141","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1002\/jbmr.2901","article-title":"SHBG, sex steroids, and kyphosis in older men: the MrOS study","volume":"31","author":"Woods","year":"2016","journal-title":"J. Bone Miner. Res."},{"issue":"12","key":"10.1016\/bs.acc.2018.06.001_bib142","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1002\/jbmr.2904","article-title":"Progressive temporal change in serum SHBG, but not in serum testosterone or estradiol, is associated with bone loss and incident fractures in older men: the concord health and ageing in men project","volume":"31","author":"Hsu","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/bs.acc.2018.06.001_bib143","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bone.2016.01.009","article-title":"Sex hormones, sex hormone binding globulin, and vertebral fractures in older men","volume":"84","author":"Cawthon","year":"2016","journal-title":"Bone"},{"key":"10.1016\/bs.acc.2018.06.001_bib144","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.steroids.2015.11.011","article-title":"The association between sex hormone-binding globulin gene polymorphism with bone mineral density","volume":"106","author":"Zha","year":"2016","journal-title":"Steroids"},{"issue":"3","key":"10.1016\/bs.acc.2018.06.001_bib145","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/jbmr.2718","article-title":"High serum SHBG predicts incident vertebral fractures in elderly men","volume":"31","author":"Vandenput","year":"2016","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/bs.acc.2018.06.001_bib146","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/jbmr.3021","article-title":"The limited clinical utility of testosterone, estradiol, and sex hormone binding globulin measurements in the prediction of fracture risk and bone loss in older men","volume":"32","author":"Orwoll","year":"2017","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib147","first-page":"33","article-title":"Testosterone, dihydrotestosterone, sex hormone-binding globulin, and incident diabetes among older men: the cardiovascular health study","volume":"102","author":"Joyce","year":"2017","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib148","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/andr.12287","article-title":"Pre-diabetes and serum sex steroid hormones among US men","volume":"5","author":"Arthur","year":"2017","journal-title":"Andrology"},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib149","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1038\/s41598-017-03078-0","article-title":"Lower SHBG level is associated with higher leptin and lower adiponectin levels as well as metabolic syndrome, independent of testosterone","volume":"7","author":"Liu","year":"2017","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/bs.acc.2018.06.001_bib150","doi-asserted-by":"crossref","first-page":"e100409","DOI":"10.1371\/journal.pone.0100409","article-title":"Testosterone, sex hormone-binding globulin and the metabolic syndrome in men: an individual participant data meta-analysis of observational studies","volume":"9","author":"Brand","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/bs.acc.2018.06.001_bib151","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/dmrr.2405","article-title":"Both total testosterone and sex hormone-binding globulin are independent risk factors for metabolic syndrome: results from Fangchenggang Area Male Health and Examination Survey in China","volume":"29","author":"Zhang","year":"2013","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"2","key":"10.1016\/bs.acc.2018.06.001_bib152","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.maturitas.2012.10.016","article-title":"Total testosterone and sex hormone-binding globulin are associated with metabolic syndrome independent of age and body mass index in Korean men","volume":"74","author":"Hong","year":"2013","journal-title":"Maturitas"},{"issue":"3","key":"10.1016\/bs.acc.2018.06.001_bib153","doi-asserted-by":"crossref","first-page":"382","DOI":"10.5604\/01.3001.0009.8593","article-title":"Testosterone, sex hormone-binding globulin and nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"16","author":"Jaruvongvanich","year":"2017","journal-title":"Ann. Hepatol."},{"issue":"4","key":"10.1016\/bs.acc.2018.06.001_bib154","doi-asserted-by":"crossref","first-page":"e2621","DOI":"10.1097\/MD.0000000000002621","article-title":"Combined association of vitamin D and sex hormone binding globulin with nonalcoholic fatty liver disease in men and postmenopausal women: a cross-sectional study","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine (Baltim.)"},{"issue":"6","key":"10.1016\/bs.acc.2018.06.001_bib155","doi-asserted-by":"crossref","first-page":"457","DOI":"10.4158\/1934-2403-8.6.457","article-title":"American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism","volume":"8","author":"Baskin","year":"2002","journal-title":"Endocr. Pract."},{"issue":"9","key":"10.1016\/bs.acc.2018.06.001_bib156","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1210\/jc.2012-1598","article-title":"Clinical review: distinguishing constitutional delay of growth and puberty from isolated hypogonadotropic hypogonadism: critical appraisal of available diagnostic tests","volume":"97","author":"Harrington","year":"2012","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"12","key":"10.1016\/bs.acc.2018.06.001_bib157","doi-asserted-by":"crossref","first-page":"5952","DOI":"10.1210\/jc.2004-0575","article-title":"A novel circulating hormone of testis origin in humans","volume":"89","author":"Foresta","year":"2004","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/bs.acc.2018.06.001_bib158","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fendo.2014.00006","article-title":"Insulin-like factor 3 and the HPG axis in the male","volume":"5","author":"Ivell","year":"2014","journal-title":"Front. Endocrinol."},{"issue":"2","key":"10.1016\/bs.acc.2018.06.001_bib159","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-2605.2010.01074.x","article-title":"Human testicular insulin-like factor 3: in relation to development, reproductive hormones and andrological disorders","volume":"34","author":"Bay","year":"2011","journal-title":"Int. J. Androl."},{"issue":"6","key":"10.1016\/bs.acc.2018.06.001_bib160","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-2605.2006.00714.x","article-title":"Peripheral INSL3 concentrations decline with age in a large population of Australian men","volume":"29","author":"Anand-Ivell","year":"2006","journal-title":"Int. J. Androl."},{"issue":"9","key":"10.1016\/bs.acc.2018.06.001_bib161","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1210\/jc.2006-0821","article-title":"Changes in serum insulin-like factor 3 during normal male puberty","volume":"91","author":"Ferlin","year":"2006","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"10","key":"10.1016\/bs.acc.2018.06.001_bib162","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/bph.13689","article-title":"Relaxin-like peptides in male reproduction - a human perspective","volume":"174","author":"Ivell","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib163","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.fertnstert.2012.09.009","article-title":"Serum insulin-like factor 3 is highly correlated with intratesticular testosterone in normal men with acute, experimental gonadotropin deficiency stimulated with low-dose human chorionic gonadotropin: a randomized, controlled trial","volume":"99","author":"Roth","year":"2013","journal-title":"Fertil. Steril."},{"key":"10.1016\/bs.acc.2018.06.001_bib164","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1749-6632.2008.03784.x","article-title":"Mutations in INSL3 and RXFP2 genes in cryptorchid boys","volume":"1160","author":"Ferlin","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/bs.acc.2018.06.001_bib165","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1749-6632.2008.03787.x","article-title":"New roles for INSL3 in adults","volume":"1160","author":"Ferlin","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"5","key":"10.1016\/bs.acc.2018.06.001_bib166","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1095\/biolreprod.105.048165","article-title":"Expression of the insulin-like peptide 3 (INSL3) hormone-receptor (LGR8) system in the testis","volume":"74","author":"Anand-Ivell","year":"2006","journal-title":"Biol. Reprod."},{"issue":"3","key":"10.1016\/bs.acc.2018.06.001_bib167","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1210\/jc.2005-1865","article-title":"The effects of gonadotropin suppression and selective replacement on insulin-like factor 3 secretion in normal adult men","volume":"91","author":"Bay","year":"2006","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"5","key":"10.1016\/bs.acc.2018.06.001_bib168","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/andr.12088","article-title":"Inhibin B, AMH, but not INSL3, IGF1 or DHEAS support differentiation between constitutional delay of growth and puberty and hypogonadotropic hypogonadism","volume":"3","author":"Rohayem","year":"2015","journal-title":"Andrology"},{"issue":"3","key":"10.1016\/bs.acc.2018.06.001_bib169","first-page":"283","article-title":"The role of gonadal peptides in clinical investigation","volume":"67","author":"Lahlou","year":"2009","journal-title":"Ann. Biol. Clin."},{"issue":"2","key":"10.1016\/bs.acc.2018.06.001_bib170","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000277140","article-title":"Anti-mullerian hormone and sertoli cell function in paediatric male hypogonadism","volume":"73","author":"Grinspon","year":"2010","journal-title":"Horm. Res. Paediatr."},{"issue":"1\u20132","key":"10.1016\/bs.acc.2018.06.001_bib171","first-page":"3","article-title":"Sertoli cell markers in the diagnosis of paediatric male hypogonadism","volume":"25","author":"Grinspon","year":"2012","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/bs.acc.2018.06.001_bib172","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1210\/er.2014-1003","article-title":"Inhibin at 90: from discovery to clinical application, a historical review","volume":"35","author":"Makanji","year":"2014","journal-title":"Endocr. Rev."},{"issue":"3","key":"10.1016\/bs.acc.2018.06.001_bib173","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000322211","article-title":"Macroorchidism and panhypopituitarism: two different forms of presentation of FSH-secreting pituitary adenomas in adolescence","volume":"75","author":"Clemente","year":"2011","journal-title":"Horm. Res. Paediatr."},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib174","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1515\/JPEM.2000.13.1.101","article-title":"Serum inhibin B concentration in a prepubertal boy with gynecomastia and Peutz-Jeghers syndrome","volume":"13","author":"Bergada","year":"2000","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/bs.acc.2018.06.001_bib175","first-page":"3692","article-title":"Inhibin B in males with gonadotropin-releasing hormone (GnRH) deficiency: changes in serum concentration after shortterm physiologic GnRH replacement\u2013a clinical research center study","volume":"81","author":"Seminara","year":"1996","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"2","key":"10.1016\/bs.acc.2018.06.001_bib176","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.2047-2927.2014.00182.x","article-title":"Inhibin B concentration is predictive for long-term azoospermia in men treated for testicular cancer","volume":"2","author":"Isaksson","year":"2014","journal-title":"Andrology"},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib177","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/cen.12613","article-title":"Inhibin B plus LH vs GnRH agonist test for distinguishing constitutional delay of growth and puberty from isolated hypogonadotropic hypogonadism in boys","volume":"82","author":"Binder","year":"2015","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib178","first-page":"147","article-title":"Congenital hypogonadotropic hypogonadism, functional hypogonadotropism or constitutional delay of growth and puberty? An analysis of a large patient series from a single tertiary center","volume":"32","author":"Varimo","year":"2017","journal-title":"Human Reprod."},{"issue":"1\u20132","key":"10.1016\/bs.acc.2018.06.001_bib179","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mce.2011.04.001","article-title":"X-linked GnRH deficiency: role of KAL-1 mutations in GnRH deficiency","volume":"346","author":"Hu","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"issue":"9","key":"10.1016\/bs.acc.2018.06.001_bib180","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nrendo.2015.112","article-title":"Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism\u2013pathogenesis, diagnosis and treatment","volume":"11","author":"Boehm","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1\u20132","key":"10.1016\/bs.acc.2018.06.001_bib181","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.mce.2011.05.041","article-title":"Genetic counseling for isolated GnRH deficiency","volume":"346","author":"Au","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib182","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/gme.0b013e3181c617e6","article-title":"Management of osteoporosis in postmenopausal women: 2010 position statement of the North American menopause society","volume":"17","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/bs.acc.2018.06.001_bib183","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000312700","article-title":"Complex genetics in idiopathic hypogonadotropic hypogonadism","volume":"39","author":"Pitteloud","year":"2010","journal-title":"Front. Horm. Res."},{"issue":"6","key":"10.1016\/bs.acc.2018.06.001_bib184","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1210\/jc.2009-2582","article-title":"Congenital idiopathic hypogonadotropic hypogonadism: evidence of defects in the hypothalamus, pituitary, and testes","volume":"95","author":"Sykiotis","year":"2010","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"34","key":"10.1016\/bs.acc.2018.06.001_bib185","doi-asserted-by":"crossref","first-page":"15140","DOI":"10.1073\/pnas.1009622107","article-title":"Oligogenic basis of isolated gonadotropin-releasing hormone deficiency","volume":"107","author":"Sykiotis","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/bs.acc.2018.06.001_bib186","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1530\/EC-17-0104","article-title":"GNRHR biallelic and digenic mutations in patients with normosmic congenital hypogonadotropic hypogonadism","volume":"6","author":"Goncalves","year":"2017","journal-title":"Endocr. Connect."},{"issue":"10","key":"10.1016\/bs.acc.2018.06.001_bib187","doi-asserted-by":"crossref","first-page":"e25614","DOI":"10.1371\/journal.pone.0025614","article-title":"Normosmic congenital hypogonadotropic hypogonadism due to TAC3\/TACR3 mutations: characterization of neuroendocrine phenotypes and novel mutations","volume":"6","author":"Francou","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/bs.acc.2018.06.001_bib188","doi-asserted-by":"crossref","first-page":"23531","DOI":"10.1038\/srep23531","article-title":"The plasma miR-125a, miR-361 and miR-133a are promising novel biomarkers for Late-Onset Hypogonadism,","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/bs.acc.2018.06.001_bib189","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1172\/JCI92846","article-title":"MicroRNA-7a2 suppression causes hypogonadotropism and uncovers signaling pathways in gonadotropes","volume":"127","author":"Crowley","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/bs.acc.2018.06.001_bib190","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1172\/JCI90031","article-title":"Loss of microRNA-7a2 induces hypogonadotropic hypogonadism and infertility","volume":"127","author":"Ahmed","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/bs.acc.2018.06.001_bib191","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1210\/jc.2016-1778","article-title":"Low testosterone: a risk marker rather than a risk factor for type 2 diabetes","volume":"101","author":"Holmboe","year":"2016","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"4","key":"10.1016\/bs.acc.2018.06.001_bib192","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2337\/diacare.27.4.861","article-title":"Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat","volume":"27","author":"Tsai","year":"2004","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/bs.acc.2018.06.001_bib193","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.2337\/dc10-2339","article-title":"Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes","volume":"34","author":"Wang","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/bs.acc.2018.06.001_bib194","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2017-02545","article-title":"Long-term testosterone administration on insulin sensitivity in older men with low or low-normal testosterone levels","author":"Huang","year":"2018","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"11","key":"10.1016\/bs.acc.2018.06.001_bib195","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1210\/jc.2007-0454","article-title":"Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism","volume":"92","author":"Yialamas","year":"2007","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"7","key":"10.1016\/bs.acc.2018.06.001_bib196","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.2337\/diacare.28.7.1636","article-title":"Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men","volume":"28","author":"Pitteloud","year":"2005","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/bs.acc.2018.06.001_bib197","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.juro.2014.11.006","article-title":"Influence of age on incident diabetes and cardiovascular disease in prostate cancer survivors receiving androgen deprivation therapy","volume":"193","author":"Morgans","year":"2015","journal-title":"J. Urol."},{"key":"10.1016\/bs.acc.2018.06.001_bib198","doi-asserted-by":"crossref","first-page":"683515","DOI":"10.1155\/2014\/683515","article-title":"Effects of long-term testosterone therapy on patients with \"diabesity\": results of observational studies of pooled analyses in obese hypogonadal men with type 2 diabetes","volume":"2014","author":"Haider","year":"2014","journal-title":"Int. J. Endocrinol."},{"issue":"3","key":"10.1016\/bs.acc.2018.06.001_bib199","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2265.2010.03942.x","article-title":"Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy","volume":"74","author":"Hamilton","year":"2011","journal-title":"Clin. Endocrinol."},{"issue":"2","key":"10.1016\/bs.acc.2018.06.001_bib200","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1210\/jc.2017-02243","article-title":"The effect of testosterone on cardiovascular biomarkers in the testosterone trials","volume":"103","author":"Mohler","year":"2018","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib201","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2337\/dc15-1518","article-title":"Insulin resistance and inflammation in hypogonadotropic hypogonadism and their reduction after testosterone replacement in men with type 2 diabetes","volume":"39","author":"Dhindsa","year":"2016","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/bs.acc.2018.06.001_bib202","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2164\/jandrol.108.007005","article-title":"Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone","volume":"30","author":"Heufelder","year":"2009","journal-title":"J. Androl."},{"issue":"3","key":"10.1016\/bs.acc.2018.06.001_bib203","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1530\/EJE-17-0673","article-title":"Diminished androgen and estrogen receptors and aromatase levels in hypogonadal diabetic men: reversal with testosterone","volume":"178","author":"Ghanim","year":"2018","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"10.1016\/bs.acc.2018.06.001_bib204","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3810\/pgm.2009.05.2001","article-title":"Hypogonadotropic hypogonadism in men with type 2 diabetes","volume":"121","author":"Dandona","year":"2009","journal-title":"Postgrad. Med."},{"issue":"9","key":"10.1016\/bs.acc.2018.06.001_bib205","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1210\/jc.2010-2724","article-title":"Update: hypogonadotropic hypogonadism in type 2 diabetes and obesity","volume":"96","author":"Dandona","year":"2011","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib206","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1530\/EC-17-0253","article-title":"Testosterone level and risk of type 2 diabetes in men: a systematic review and meta-analysis","volume":"7","author":"Yao","year":"2018","journal-title":"Endocr. Connect."},{"issue":"3","key":"10.1016\/bs.acc.2018.06.001_bib207","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/13685530802317934","article-title":"Hypogonadotrophic hypogonadism in type 2 diabetes","volume":"11","author":"Dandona","year":"2008","journal-title":"Aging Male"},{"issue":"8","key":"10.1016\/bs.acc.2018.06.001_bib208","doi-asserted-by":"crossref","first-page":"816","DOI":"10.2174\/156652408786733658","article-title":"Hypogonadotrophic hypogonadism in type 2 diabetes, obesity and the metabolic syndrome","volume":"8","author":"Dandona","year":"2008","journal-title":"Curr. Mol. Med."},{"issue":"11","key":"10.1016\/bs.acc.2018.06.001_bib209","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.1210\/jc.2004-0804","article-title":"Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes","volume":"89","author":"Dhindsa","year":"2004","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib210","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1530\/EC-12-0057","article-title":"Inverse association between serum insulin and sex hormone-binding globulin in a population survey in Sweden","volume":"2","author":"Daka","year":"2013","journal-title":"Endocr. Connect."},{"issue":"12","key":"10.1016\/bs.acc.2018.06.001_bib211","doi-asserted-by":"crossref","first-page":"E2780","DOI":"10.1210\/jc.2014-2640","article-title":"Sex hormone-binding globulin gene expression and insulin resistance","volume":"99","author":"Winters","year":"2014","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"12","key":"10.1016\/bs.acc.2018.06.001_bib212","first-page":"3979","article-title":"Monosaccharide-induced lipogenesis regulates the human hepatic sex hormone-binding globulin gene","volume":"117","author":"Selva","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/bs.acc.2018.06.001_bib213","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2337\/diacare.25.2.275","article-title":"Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the diabetes control and complications trial","volume":"25","author":"Rohlfing","year":"2002","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/bs.acc.2018.06.001_bib214","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1038\/oby.2007.356","article-title":"Anatomical patterning of visceral adipose tissue: race, sex, and age variation","volume":"15","author":"Demerath","year":"2007","journal-title":"Obesity"},{"issue":"7","key":"10.1016\/bs.acc.2018.06.001_bib215","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1023\/B:EJEP.0000036809.30558.8f","article-title":"Waist circumference and testosterone levels in community dwelling men. The Tromso study","volume":"19","author":"Svartberg","year":"2004","journal-title":"Eur. J. Epidemiol."},{"issue":"4","key":"10.1016\/bs.acc.2018.06.001_bib216","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/ijir.2008.19","article-title":"Testosterone treatment in elderly men with subnormal testosterone levels improves body composition and BMD in the hip","volume":"20","author":"Svartberg","year":"2008","journal-title":"Int. J. Impot. Res."},{"issue":"5","key":"10.1016\/bs.acc.2018.06.001_bib217","doi-asserted-by":"crossref","first-page":"E1009","DOI":"10.1152\/ajpendo.00536.2002","article-title":"Development of models to predict anabolic response to testosterone administration in healthy young men","volume":"284","author":"Woodhouse","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/bs.acc.2018.06.001_bib218","doi-asserted-by":"crossref","first-page":"e31473","DOI":"10.1371\/journal.pone.0031473","article-title":"Effects of male hypogonadism on regional adipose tissue fatty acid storage and lipogenic proteins","volume":"7","author":"Santosa","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/bs.acc.2018.06.001_bib219","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1210\/jc.2017-00757","article-title":"Acute testosterone deficiency alters adipose tissue fatty acid storage","volume":"102","author":"Santosa","year":"2017","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"9","key":"10.1016\/bs.acc.2018.06.001_bib220","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jsxm.2017.06.015","article-title":"Low plasma testosterone is associated with elevated cardiovascular disease biomarkers","volume":"14","author":"Pastuszak","year":"2017","journal-title":"J. Sex. Med."},{"issue":"2","key":"10.1016\/bs.acc.2018.06.001_bib221","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1530\/EJE-14-1103","article-title":"High aromatase activity in hypogonadal men is associated with higher spine bone mineral density, increased truncal fat and reduced lean mass","volume":"173","author":"Aguirre","year":"2015","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/bs.acc.2018.06.001_bib222","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13533","article-title":"Effects of short-term sex steroid suppression on dietary fat storage patterns in healthy males","volume":"6","author":"Rynders","year":"2018","journal-title":"Physiol. Rep."},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib223","first-page":"15","article-title":"Sex and sex steroids: impact on the kinetics of fatty acids underlying body shape","volume":"20","author":"Santosa","year":"2014","journal-title":"Horm. Mol. Biol. Clin. Invest."},{"issue":"4","key":"10.1016\/bs.acc.2018.06.001_bib224","doi-asserted-by":"crossref","first-page":"828","DOI":"10.2337\/dc10-1233","article-title":"Testosterone replacement in hypogonadal men with type 2 diabetes and\/or metabolic syndrome (the TIMES2 study)","volume":"34","author":"Jones","year":"2011","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/bs.acc.2018.06.001_bib225","doi-asserted-by":"crossref","first-page":"e0187741","DOI":"10.1371\/journal.pone.0187741","article-title":"Circulating sex hormones in relation to anthropometric, sociodemographic and behavioural factors in an international dataset of 12,300 men","volume":"12","author":"Watts","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/bs.acc.2018.06.001_bib226","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.2047-2927.2014.00218.x","article-title":"Distinct roles of age and abdominal visceral fat in reducing androgen receptor-dependent negative feedback on LH secretion in healthy men","volume":"2","author":"Takahashi","year":"2014","journal-title":"Andrology"},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib227","doi-asserted-by":"crossref","first-page":"E117","DOI":"10.1152\/ajpendo.00450.2011","article-title":"Older men exhibit reduced efficacy of and heightened potency downregulation by intravenous pulses of recombinant human LH: a study in 92 healthy men","volume":"302","author":"Veldhuis","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"Pt 2","key":"10.1016\/bs.acc.2018.06.001_bib228","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.mce.2015.06.031","article-title":"Obesity and late-onset hypogonadism","volume":"418","author":"Corona","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"issue":"13","key":"10.1016\/bs.acc.2018.06.001_bib229","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1055\/s-0033-1355399","article-title":"Interaction between energy homeostasis and reproduction: central effects of leptin and ghrelin on the reproductive axis","volume":"45","author":"Tena-Sempere","year":"2013","journal-title":"Horm. Metab. Res."},{"issue":"3","key":"10.1016\/bs.acc.2018.06.001_bib230","first-page":"141","article-title":"Role of the adipocyte-derived hormone\u00a0leptin in reproductive control","volume":"19","author":"Garcia-Galiano","year":"2014","journal-title":"Horm. Mol. Biol. Clin. Invest."},{"issue":"4","key":"10.1016\/bs.acc.2018.06.001_bib231","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2826.2006.01417.x","article-title":"KiSS-1 neurones are direct\u00a0targets for leptin in the ob\/ob mouse","volume":"18","author":"Smith","year":"2006","journal-title":"J. Neuroendocrinol."},{"issue":"3","key":"10.1016\/bs.acc.2018.06.001_bib232","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/oby.21754","article-title":"Acute recapitulation of the hyperinsulinemia and hyperlipidemia characteristic of\u00a0metabolic syndrome suppresses gonadotropins","volume":"25","author":"Chosich","year":"2017","journal-title":"Obesity"},{"issue":"9","key":"10.1016\/bs.acc.2018.06.001_bib233","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1210\/jc.2017-00967","article-title":"Changes in visceral adiposity, subcutaneous adiposity, and sex hormones in the diabetes prevention program","volume":"102","author":"Kim","year":"2017","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib234","doi-asserted-by":"crossref","first-page":"e0189042","DOI":"10.1371\/journal.pone.0189042","article-title":"Association of sex hormones with physical, laboratory, and imaging markers of anthropometry in men and women from the general population","volume":"13","author":"Seyfart","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib235","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1590\/2359-3997000000203","article-title":"Importance of abdominal circumference and body mass index values in predicting male hypogonadism - a practical approach","volume":"61","author":"Jaworski","year":"2017","journal-title":"Arch. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/bs.acc.2018.06.001_bib236","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1590\/2359-3997000000236","article-title":"Visceral adiposity index and triglyceride\/high-density lipoprotein cholesterol ratio in hypogonadism","volume":"61","author":"Haymana","year":"2017","journal-title":"Arch. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2018.06.001_bib237","doi-asserted-by":"crossref","first-page":"19844","DOI":"10.1038\/srep19844","article-title":"Visceral fat dysfunction is positively associated with hypogonadism in Chinese men","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib238","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.bbrc.2016.12.149","article-title":"Circadian clock and steroidogenic-related gene expression profiles in mouse Leydig cells following dexamethasone stimulation","volume":"483","author":"Chen","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/bs.acc.2018.06.001_bib239","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12610-016-0034-7","article-title":"Gut Endotoxin Leading to a Decline IN Gonadal function (GELDING) - a novel theory for the development of late onset hypogonadism in obese men","volume":"26","author":"Tremellen","year":"2016","journal-title":"Basic Clin. Androl."},{"issue":"4","key":"10.1016\/bs.acc.2018.06.001_bib240","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10753-009-9177-4","article-title":"Bacterial LPS-mediated acute inflammation-induced spermatogenic failure in rats: role of stress response proteins and mitochondrial dysfunction","volume":"33","author":"Metukuri","year":"2010","journal-title":"Inflammation"},{"issue":"4","key":"10.1016\/bs.acc.2018.06.001_bib241","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/jcb.25374","article-title":"Sirtuin 4 regulates lipopolysaccharide mediated Leydig cell dysfunction","volume":"117","author":"Ramatchandirin","year":"2016","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/bs.acc.2018.06.001_bib242","doi-asserted-by":"crossref","first-page":"e02481","DOI":"10.1128\/mBio.02481-14","article-title":"Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide","volume":"6","author":"Romano","year":"2015","journal-title":"mBio"},{"issue":"3","key":"10.1016\/bs.acc.2018.06.001_bib243","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3945\/ajcn.115.121269","article-title":"Plasma trimethylamine N-oxide concentration is associated with choline, phospholipids, and methyl metabolism","volume":"103","author":"Obeid","year":"2016","journal-title":"Am. J. Clin. Nutr."},{"issue":"36","key":"10.1016\/bs.acc.2018.06.001_bib244","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.2174\/0929867323666160830104025","article-title":"The metabolite trimethylamine-N-oxide is an emergent biomarker of human health","volume":"24","author":"Chhibber-Goel","year":"2017","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib245","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1681\/ASN.2014111063","article-title":"Serum trimethylamine-N-oxide is elevated in CKD and correlates with coronary atherosclerosis burden","volume":"27","author":"Stubbs","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/bs.acc.2018.06.001_bib246","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00008571-199508000-00008","article-title":"Dysfunctional N-oxidation of trimethylamine and the influence of testosterone treatment in man","volume":"5","author":"Ayesh","year":"1995","journal-title":"Pharmacogenetics"},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib247","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.celrep.2017.06.053","article-title":"The TMAO-producing enzyme flavin-containing monooxygenase 3 regulates obesity and the beiging of white adipose tissue","volume":"20","author":"Schugar","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/bs.acc.2018.06.001_bib248","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2014.12.036","article-title":"The TMAO-generating enzyme flavin monooxygenase 3 is a central regulator of cholesterol balance","author":"Warrier","year":"2015","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib249","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cmet.2012.12.011","article-title":"Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation","volume":"17","author":"Bennett","year":"2013","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib250","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1373\/clinchem.2016.263640","article-title":"Increased trimethylamine N-Oxide portends high mortality risk independent of glycemic control in patients with type 2 diabetes mellitus","volume":"63","author":"Tang","year":"2017","journal-title":"Clin. Chem."},{"issue":"3","key":"10.1016\/bs.acc.2018.06.001_bib251","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/CIRCRESAHA.116.305360","article-title":"Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease","volume":"116","author":"Tang","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/bs.acc.2018.06.001_bib252","article-title":"Endotoxin initiated inflammation reduces testosterone production in men of reproductive age","author":"Tremellen","year":"2017","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2018.06.001_bib253","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12610-017-0049-8","article-title":"Metabolic endotoxaemia related inflammation is associated with hypogonadism in overweight men","volume":"27","author":"Tremellen","year":"2017","journal-title":"Basic Clin. Androl."},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib254","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.atherosclerosis.2015.04.814","article-title":"Increased adipose tissue secretion of Fetuin-A, lipopolysaccharide-binding protein and high-mobility group box protein 1 in metabolic syndrome","volume":"241","author":"Jialal","year":"2015","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/bs.acc.2018.06.001_bib255","doi-asserted-by":"crossref","first-page":"e015910","DOI":"10.1136\/bmjopen-2017-015910","article-title":"Association of endotoxaemia with serum free fatty acids in metabolically healthy and unhealthy abdominally obese individuals: a case-control study in northwest of Iran","volume":"7","author":"Saghafi-Asl","year":"2017","journal-title":"BMJ Open"},{"issue":"11","key":"10.1016\/bs.acc.2018.06.001_bib256","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1007\/s00125-013-3015-9","article-title":"A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction","volume":"56","author":"Moreno-Navarrete","year":"2013","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/bs.acc.2018.06.001_bib257","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2337\/dc15-1777","article-title":"Association of lipopolysaccharide-binding protein with aging-related adiposity change and prediabetes among African Ancestry men","volume":"39","author":"Tilves","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/bs.acc.2018.06.001_bib258","doi-asserted-by":"crossref","first-page":"23001","DOI":"10.1038\/srep23001","article-title":"Castration influences intestinal microflora and induces abdominal obesity in high-fat diet-fed mice","volume":"6","author":"Harada","year":"2016","journal-title":"Sci. Rep."},{"issue":"7341","key":"10.1016\/bs.acc.2018.06.001_bib259","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"issue":"17","key":"10.1016\/bs.acc.2018.06.001_bib260","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","article-title":"Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk","volume":"368","author":"Tang","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"11\u201312","key":"10.1016\/bs.acc.2018.06.001_bib261","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.nut.2015.05.006","article-title":"TMAO: a small molecule of great expectations","volume":"31","author":"Ufnal","year":"2015","journal-title":"Nutrition"},{"issue":"3","key":"10.1016\/bs.acc.2018.06.001_bib262","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1210\/jc.2004-1933","article-title":"Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T","volume":"90","author":"Page","year":"2005","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"8","key":"10.1016\/bs.acc.2018.06.001_bib263","first-page":"2647","article-title":"Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age","volume":"84","author":"Snyder","year":"1999","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"2","key":"10.1016\/bs.acc.2018.06.001_bib264","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1210\/jc.2009-1251","article-title":"Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study","volume":"95","author":"Srinivas-Shankar","year":"2010","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"2","key":"10.1016\/bs.acc.2018.06.001_bib265","first-page":"583","article-title":"Effects of testosterone supplementation for 3 Years on muscle performance and physical function in older men","volume":"102","author":"Storer","year":"2017","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/bs.acc.2018.06.001_bib266","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bone.2015.02.008","article-title":"Skeletal muscle as an endocrine organ: PGC-1alpha, myokines and exercise","volume":"80","author":"Schnyder","year":"2015","journal-title":"Bone"},{"issue":"11","key":"10.1016\/bs.acc.2018.06.001_bib267","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1111\/ggi.13030","article-title":"Circulating irisin levels as a predictive biomarker for sarcopenia: a cross-sectional community-based study","volume":"17","author":"Chang","year":"2017","journal-title":"Geriatr. Gerontol. Int."},{"issue":"3\u20134","key":"10.1016\/bs.acc.2018.06.001_bib268","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bbrc.2010.11.061","article-title":"Protection against dexamethasone-induced muscle atrophy is related to modulation by testosterone of FOXO1 and PGC-1alpha","volume":"403","author":"Qin","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib269","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12020-016-0913-x","article-title":"The role of sex, adiposity, and gonadectomy in the regulation of irisin secretion","volume":"54","author":"Zugel","year":"2016","journal-title":"Endocrine"},{"issue":"10","key":"10.1016\/bs.acc.2018.06.001_bib270","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1055\/s-0043-115227","article-title":"Irisin and testosterone in men with metabolic syndrome","volume":"49","author":"Kamenov","year":"2017","journal-title":"Horm. Metab. Res."},{"issue":"11","key":"10.1016\/bs.acc.2018.06.001_bib271","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1210\/jc.2009-1434","article-title":"N-terminal propeptide of type III procollagen as a biomarker of anabolic response to recombinant human GH and testosterone","volume":"94","author":"Bhasin","year":"2009","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"4","key":"10.1016\/bs.acc.2018.06.001_bib272","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/jcsm.12027","article-title":"Collagen fragment biomarkers as serological biomarkers of lean body mass - a biomarker pilot study from the DAHANCA25B cohort and matched controls","volume":"6","author":"Nedergaard","year":"2015","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"12","key":"10.1016\/bs.acc.2018.06.001_bib273","doi-asserted-by":"crossref","first-page":"e0144525","DOI":"10.1371\/journal.pone.0144525","article-title":"Collagen type III and VI turnover in response to long-term immobilization","volume":"10","author":"Sun","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib274","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s13539-011-0021-y","article-title":"Evaluation of early biomarkers of muscle anabolic response to testosterone","volume":"2","author":"Chen","year":"2011","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"2","key":"10.1016\/bs.acc.2018.06.001_bib275","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s13539-013-0120-z","article-title":"Biomarkers of muscle quality: N-terminal propeptide of type III procollagen and C-terminal agrin fragment responses to resistance exercise training in older adults","volume":"5","author":"Fragala","year":"2014","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib276","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.exger.2012.05.021","article-title":"C-terminal Agrin Fragment as a potential marker for sarcopenia caused by degeneration of the neuromuscular junction","volume":"48","author":"Drey","year":"2013","journal-title":"Exp. Gerontol."},{"issue":"1","key":"10.1016\/bs.acc.2018.06.001_bib277","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/andr.12424","article-title":"Testosterone does not affect agrin cleavage in mobility-limited older men despite improvement in physical function","volume":"6","author":"Gagliano-Juca","year":"2018","journal-title":"Andrology"}],"container-title":["Advances in Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242318300350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242318300350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T19:37:40Z","timestamp":1758742660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065242318300350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9780128152041"],"references-count":277,"URL":"https:\/\/doi.org\/10.1016\/bs.acc.2018.06.001","relation":{},"ISSN":["0065-2423"],"issn-type":[{"value":"0065-2423","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}